NLM Logo

telisotuzumab vedotin MeSH Supplementary Concept Data 2024


MeSH Supplementary
telisotuzumab vedotin
Unique ID
C000626235
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000626235
Entry Term(s)
ABBV-399
ABT-399
ABT-700-VCMMAE
PR-1420682
Registry Number
976X9VXC3Z
Heading Mapped to
*Antibodies, Monoclonal
Frequency
6
Note
c-Met antibody-drug conjugate that targets both MET-amplified and c-Met-overexpressing tumors, irrespective of MET pathway dependence
Source
Clin Cancer Res. 2017 Feb 15;23(4)992-1000
Date of Entry
2018/02/12
Revision Date
2019/11/01
telisotuzumab vedotin Preferred
PR-1420682 Narrower
ABT-700-VCMMAE Narrower
ABBV-399 Narrower
page delivered in 0.006s